ストックスクリーナーアプリを入手
8.52
2.77%
0.23
前日終値:
$8.29
開ける：
$8.31
24時間の取引高:
2.93M
Relative Volume:
1.62
時価総額：
$874.80M
収益：
$187.64M
当期純損益:
$-95.00M
株価収益率:
-8.9684
EPS:
-0.95
ネットキャッシュフロー:
$-69.02M
1週間 パフォーマンス:
-3.18%
1か月 パフォーマンス:
+13.45%
6か月 パフォーマンス:
+35.45%
1年 パフォーマンス:
-36.13%
1日の値動き範囲:
$8.16
$8.70
1週間の範囲:
$8.16
$9.395
52週間の値動き範囲:
$5.635
$14.46
Day One Biopharmaceuticals Inc Stock (DAWN) Company Profile
名前
Day One Biopharmaceuticals Inc
セクター
電話
650 484-0899
住所
1800 SIERRA POINT PARKWAY, SUITE 200, BRISBANE
DAWN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DAWN
Day One Biopharmaceuticals Inc
|
8.52 | 851.18M | 187.64M | -95.00M | -69.02M | -0.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Day One Biopharmaceuticals Inc Stock (DAWN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-19 | 開始されました | Piper Sandler | Overweight |
| 2024-10-09 | 繰り返されました | Needham | Buy |
| 2024-08-01 | アップグレード | BofA Securities | Underperform → Buy |
| 2024-04-24 | 繰り返されました | Needham | Buy |
| 2023-04-25 | ダウングレード | BofA Securities | Buy → Underperform |
| 2023-02-08 | 開始されました | CapitalOne | Overweight |
| 2023-02-03 | 開始されました | Oppenheimer | Perform |
| 2022-12-15 | 開始されました | H.C. Wainwright | Buy |
| 2022-12-14 | 開始されました | Needham | Buy |
| 2022-12-05 | 開始されました | Goldman | Buy |
| 2022-12-01 | 開始されました | BofA Securities | Buy |
すべてを表示
Day One Biopharmaceuticals Inc (DAWN) 最新ニュース
Is Day One Biopharmaceuticals Inc a good long term investmentRisk Adjusted Returns & High Profit Market Tips - earlytimes.in
Day One Biopharmaceuticals unveils promising Phase 2 trial data - Traders Union
Will Day One Biopharmaceuticals Inc. stock maintain momentum in 2025Trade Analysis Report & Verified Chart Pattern Trade Signals - newser.com
Can Day One Biopharmaceuticals Inc. stock maintain growth trajectoryWeekly Stock Summary & Technical Confirmation Trade Alerts - newser.com
Wall Street Analysts Believe Day One Biopharmaceuticals (DAWN) Could Rally 161.36%: Here's is How to Trade - MSN
Can Day One Biopharmaceuticals Inc. stock deliver consistent earnings growthJuly 2025 Breakouts & Real-Time Market Trend Scan - newser.com
Will Day One Biopharmaceuticals Inc. stock recover faster than peersAnalyst Upgrade & Safe Entry Zone Tips - newser.com
Day One Biopharmaceuticals, Inc.Common Stock (NQ: DAWN - FinancialContent
Day one biopharma gen counsel sells $38k in shares By Investing.com - Investing.com South Africa
Can Day One Biopharmaceuticals Inc. rally from current levelsQuarterly Trade Review & Free Low Drawdown Momentum Trade Ideas - newser.com
Key resistance and support levels for Day One Biopharmaceuticals Inc.Index Update & Safe Swing Trade Setup Alerts - newser.com
Day One Biopharmaceuticals Inc. stock volume spike explainedTrade Signal Summary & Weekly High Conviction Trade Ideas - newser.com
Day one biopharma gen counsel sells $38k in shares - Investing.com India
[Form 4] Day One Biopharmaceuticals, Inc. Insider Trading Activity - Stock Titan
COO York II Acquires 12,813 Of Day One Biopharmaceuticals Inc [DAWN] - TradingView
Day One Biopharmaceuticals CEO Jeremy Bender Sells Shares - TradingView
What Fibonacci levels say about Day One Biopharmaceuticals Inc. reboundTake Profit & Daily Profit Focused Stock Screening - newser.com
Key deals this week: Merck, Day One Biopharmaceutical, ABN AMRO, Revvity, Centerspace and more - MSN
Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference - The Manila Times
Avadel deems Lundbeck offer ‘superior’ to Alkermes’: Deals Report - BioCentury
Day One Biopharmaceuticals to Acquire Mersana Therapeutics in $285 Million Deal - Global Legal Chronicle
Officer Merendino Files To Sell 3,726 Of Day One Biopharmaceuticals Inc [DAWN] - TradingView
What Wall Street predicts for Day One Biopharmaceuticals Inc. stock priceEarnings Risk Summary & Advanced Technical Analysis Signals - newser.com
(DAWN) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
Will Day One Biopharmaceuticals Inc. stock maintain growth storyJuly 2025 Analyst Calls & Growth Focused Investment Plans - newser.com
Forecasting Day One Biopharmaceuticals Inc. price range with options dataMarket Risk Analysis & Free Low Drawdown Momentum Trade Ideas - newser.com
MRSN Stock Soars Over 200% Pre-Market After Day One Acquisition Deal - Stocktwits
Day One Biopharmaceuticals Inc. stock outlook for YEARLayoff News & Real-Time Volume Analysis Alerts - newser.com
Day One to buy Mersana Therapeutics for $25/share upfront - MSN
Key deals this week: Merck, Day One Biopharmaceutical, ABN AMRO, Revvity, Centerspace and more (BX:NYSE) - Seeking Alpha
Mersana Therapeutics Faces High Stakes with Potential Day One Biopharmaceuticals Merger Delays - MSN
Day One Biopharmaceuticals Inc (DAWN) 財務データ
収益
当期純利益
現金流量
EPS
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):